PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

por Pinczes, L. I., Magyari, F., Páyer, E., Farkas, K., Ujfalusi, S., Diószegi, Á., Deme, A., Sik, M., Nagy, G., Hevessy, Z., Nagy, B., Illés, Á.
Publicado 2022